FDA Updates and Press Announcements on Nitrosamines in Rifampin and Rifapentine

To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and UTMB collaborate to provide an annual training course on how to meet GLP requirements in BSL-4 facilities

Find out which specific blood pressure medications are affected by the recall

Get updates on the recalls

Get current information about recalls of blood pressure medications

FDA Updates and Press Announcements on NDMA in Metformin

FDA alerts health care professionals and patients to voluntary recall of ranitidine medicines

Generic Drug Facilities, Sites and Organization Lists

Fiscal Year (FY) 2017 GDUFA facility fees are due on October 3, 2016.

It's important to safeguard your food, water, medicine and pets before, during and after any severe weather event.